James M. McLenachan

3.5k total citations · 2 hit papers
48 papers, 2.8k citations indexed

About

James M. McLenachan is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, James M. McLenachan has authored 48 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in James M. McLenachan's work include Acute Myocardial Infarction Research (10 papers), Cardiac Imaging and Diagnostics (8 papers) and Cardiovascular Function and Risk Factors (8 papers). James M. McLenachan is often cited by papers focused on Acute Myocardial Infarction Research (10 papers), Cardiac Imaging and Diagnostics (8 papers) and Cardiovascular Function and Risk Factors (8 papers). James M. McLenachan collaborates with scholars based in United Kingdom, United States and France. James M. McLenachan's co-authors include Henry J. Dargie, Peter Ganz, Andrew P. Selwyn, Esther Henderson, R. David Fish, Joseph A. Vita, Charles B. Treasure, Karen I. Morris, Alan C. Yeung and E G Nabel and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

James M. McLenachan

48 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.

1990 954 citations Joseph A. Vita, Charles B. Treasure et al. Circulation profile →
Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular Hypertrophy

1987 462 citations James M. McLenachan, Esther Henderson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James M. McLenachan United Kingdom	16	2.1k	593	562	489	282	48	2.8k
Takeshi Motoyama Japan	26	1.8k 0.9×	1000 1.7×	623 1.1×	707 1.4×	710 2.5×	38	3.5k
Charles B. Treasure United States	14	2.0k 0.9×	1.1k 1.8×	678 1.2×	677 1.4×	306 1.1×	23	2.8k
David Hasdai United States	26	1.7k 0.8×	579 1.0×	861 1.5×	679 1.4×	232 0.8×	78	2.7k
R. David Fish United States	17	2.1k 1.0×	1.1k 1.8×	792 1.4×	696 1.4×	272 1.0×	47	3.1k
Gabriele Fragasso Italy	29	2.0k 0.9×	456 0.8×	520 0.9×	897 1.8×	244 0.9×	144	3.0k
Yuji Miyao Japan	24	1.3k 0.6×	326 0.5×	538 1.0×	310 0.6×	392 1.4×	57	2.5k
S.W. Werns United States	25	1.0k 0.5×	416 0.7×	573 1.0×	371 0.8×	97 0.3×	62	2.3k
Gian Gastone Neri Serneri Italy	34	1.8k 0.9×	437 0.7×	661 1.2×	226 0.5×	367 1.3×	118	3.3k
M Bertrand France	24	1.8k 0.9×	283 0.5×	1.2k 2.2×	804 1.6×	530 1.9×	64	2.9k
Raymond D. Magorien United States	28	2.5k 1.2×	187 0.3×	1.3k 2.2×	595 1.2×	237 0.8×	65	3.7k

Countries citing papers authored by James M. McLenachan

Since Specialization

Citations

This map shows the geographic impact of James M. McLenachan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. McLenachan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. McLenachan more than expected).

Fields of papers citing papers by James M. McLenachan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. McLenachan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. McLenachan. The network helps show where James M. McLenachan may publish in the future.

Co-authorship network of co-authors of James M. McLenachan

This figure shows the co-authorship network connecting the top 25 collaborators of James M. McLenachan. A scholar is included among the top collaborators of James M. McLenachan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. McLenachan. James M. McLenachan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McLenachan, James M., Huon Gray, Mark de Belder, et al.. (2012). Developing primary PCI as a national reperfusion strategy for patients with ST-elevation myocardial infarction: the UK experience. EuroIntervention. 8(P). P99–P107. 13 indexed citations

Shelton, Rhidian J., Andrew Crean, Kathryn Somers, et al.. (2010). Real-world outcome from ST elevation myocardial infarction in the very elderly before and after the introduction of a 24/7 primary percutaneous coronary intervention service. American Heart Journal. 159(6). 956–963. 17 indexed citations

West, Robert, Brian A. Cattle, I B Squire, et al.. (2010). Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. European Heart Journal. 32(6). 706–711. 52 indexed citations

Greenwood, John P., Kathryn Somers, Stephen G. Wheatcroft, et al.. (2008). Direct ambulance admission to the cardiac catheterization laboratory significantly reduces door-to-balloon times in primary percutaneous coronary intervention. American Heart Journal. 155(6). 1054–1058. 57 indexed citations

Nolan, James, et al.. (1997). Feasibility and applicability of coronary stent implantation with the direct brachial approach: Results of a single-center study. American Heart Journal. 134(5). 939–944. 5 indexed citations

Stewart, Debra, Sujit K. Ghosh, G. J. A. Macphee, et al.. (1992). Terodiline causes polymorphic ventricular tachycardia due to reduced heart rate and prolongation of QT interval. European Journal of Clinical Pharmacology. 42(6). 577–80. 39 indexed citations

McLenachan, James M. & Henry J. Dargie. (1991). Determinants of Ventricular Arrhythmias in Cardiac Hypertrophy. Journal of Cardiovascular Pharmacology. 17(Supplement 2). S46–S49. 4 indexed citations

Cleland, John G.F., Esther Henderson, James M. McLenachan, Iain Findlay, & Henry J. Dargie. (1991). Effect of Captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. Journal of the American College of Cardiology. 17(3). 733–739. 64 indexed citations

McLenachan, James M., Franz Weidinger, Joan Barry, et al.. (1991). Relations between heart rate, ischemia, and drug therapy during daily life in patients with coronary artery disease.. Circulation. 83(4). 1263–1270. 47 indexed citations

10.

McLenachan, James M., Stanley Grant, Ian Ford, Esther Henderson, & Henry J. Dargie. (1991). Submaximal, but not maximal, exercise testing detects differences in the effects of β-blockers during treadmill exercise: A study of celiprolol and atenolol. II. American Heart Journal. 121(2). 691–696. 8 indexed citations

11.

Gibbs, J. Simon R., Howard M. McAlpine, Christine E. Wright, et al.. (1991). Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina. International Journal of Cardiology. 31(3). 281–286. 4 indexed citations

12.

McLenachan, James M., J. Koudy Williams, R. David Fish, Peter Ganz, & Andrew P. Selwyn. (1991). Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis.. Circulation. 84(3). 1273–1278. 131 indexed citations

13.

McLenachan, James M. & Henry J. Dargie. (1991). A review of the clinical experience with celiprolol in angina. American Heart Journal. 121(2). 688–690. 2 indexed citations

14.

Vita, Joseph A., Charles B. Treasure, E G Nabel, et al.. (1990). Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.. Circulation. 81(2). 491–497. 954 indexed citations breakdown →

15.

McLenachan, James M. & Henry J. Dargie. (1990). A review of rhythm disorders in cardiac hypertrophy. The American Journal of Cardiology. 65(14). 42–44. 12 indexed citations

16.

Stott, David J., J. I. S. Robertson, James M. McLenachan, & Stephen G. Ball. (1989). Effects of short‐term ketanserin treatment on the QT interval and vagal function in healthy subjects. Journal of Autonomic Pharmacology. 9(1). 45–52. 3 indexed citations

17.

McLenachan, James M., John T. Wilson, & Henry J. Dargie. (1988). Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.. Heart. 59(6). 685–689. 11 indexed citations

18.

McLenachan, James M., Iain Findlay, Esther Henderson, John T. Wilson, & Henry J. Dargie. (1988). Atenolol and celiprolol for stable angina pectoris. The American Journal of Cardiology. 61(5). C52–C52. 7 indexed citations

19.

McInnes, Gordon T., James M. McLenachan, Esther Henderson, Ariane L. Herrick, & Henry J. Dargie. (1988). Celiprolol and verapamil in the treatment of essential hypertension. American Heart Journal. 116(5). 1437–1438. 7 indexed citations

20.

McLenachan, James M., John T. Wilson, & Henry Dargie. (1988). Improved left ventricular function during exercise: A comparison of celiprolol and atenolol. American Heart Journal. 116(5). 1435–1436. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact